Literature DB >> 16699860

Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species.

Yuichi Hara1, Keisuke Hino, Michiari Okuda, Takakazu Furutani, Isao Hidaka, Yuhki Yamaguchi, Masaaki Korenaga, Kui Li, Steven A Weinman, Stanley M Lemon, Kiwamu Okita.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) core protein is known to cause oxidative stress and alter apoptosis pathways. However, the apoptosis results are inconsistent, and the real significance of oxidative stress is not well known. The aim of this study was twofold. First, we wanted to confirm whether core-induced oxidative stress was really significant enough to cause DNA damage, and whether it induced cellular antioxidant responses. Second, we wanted to evaluate whether this core-induced oxidative stress and the antioxidant response to it was responsible for apoptosis changes.
METHODS: HCV core protein was expressed under control of the Tet-Off promoter in Huh-7 cells and HeLa cells. We chose to use deoxycholic acid (DCA) as a model because it is known to produce both reactive oxygen species (ROS) and apoptosis.
RESULTS: Core expression uniformly increased ROS and 8-hydroxy-2'-deoxyguanosine (8-OHdG) under basal and DCA-stimulated conditions. Core protein expression also increased manganese superoxide dismutase levels. Core protein inhibited DCA-mediated mitochondrial membrane depolarization and DCA-mediated activation of caspase-9 and caspase-3, despite the increase in ROS by DCA. Core protein inhibited DCA-mediated apoptosis by increasing Bcl-x(L) protein and decreasing Bax protein, without affecting the proportion of Bax between mitochondria and cytosol, resulting in suppression of cytochrome c release from mitochondria into cytoplasm.
CONCLUSIONS: HCV core protein induces oxidative DNA damage, whereas it inhibits apoptosis that is accompanied by enhancement of ROS production. Thus, oxidative stress and apoptosis modulation by core protein are independent of each other.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699860     DOI: 10.1007/s00535-005-1738-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  44 in total

1.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC.

Authors:  S Shimizu; M Narita; Y Tsujimoto
Journal:  Nature       Date:  1999-06-03       Impact factor: 49.962

2.  An infectious molecular clone of a Japanese genotype 1b hepatitis C virus.

Authors:  M R Beard; G Abell; M Honda; A Carroll; M Gartland; B Clarke; K Suzuki; R Lanford; D V Sangar; S M Lemon
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

3.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis.

Authors:  D I Tai; S L Tsai; Y M Chen; Y L Chuang; C Y Peng; I S Sheen; C T Yeh; K S Chang; S N Huang; G C Kuo; Y F Liaw
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

5.  Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Authors:  N Zhu; A Khoshnan; R Schneider; M Matsumoto; G Dennert; C Ware; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection.

Authors:  F Farinati; R Cardin; P Degan; N De Maria; R A Floyd; D H Van Thiel; R Naccarato
Journal:  Free Radic Biol Med       Date:  1999-12       Impact factor: 7.376

7.  Human T-cell leukemia virus type I tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T-cells through nuclear factor-kappaB and c-AMP responsive element binding protein pathways.

Authors:  N Mori; M Fujii; G Cheng; S Ikeda; Y Yamasaki; Y Yamada; M Tomonaga; N Yamamoto
Journal:  Virus Genes       Date:  2001-06       Impact factor: 2.332

8.  Apoptotic cell death does not parallel other indicators of liver damage in chronic hepatitis C patients.

Authors:  C M Rodrigues; D Brites; F Serejo; A Costa; F Ramalho; M C De Moura
Journal:  J Viral Hepat       Date:  2000-05       Impact factor: 3.728

9.  Morphological transformation by 8-hydroxy-2'-deoxyguanosine in Syrian hamster embryo (SHE) cells.

Authors:  H Zhang; Y Xu; L M Kamendulis; J E Klaunig
Journal:  Toxicol Sci       Date:  2000-08       Impact factor: 4.849

10.  Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein.

Authors:  R B Ray; K Meyer; R Steele; A Shrivastava; B B Aggarwal; R Ray
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

View more
  14 in total

1.  Oxidative stress and apoptosis in hepatitis C: the core issue.

Authors:  Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

2.  Induction of endoplasmic reticulum-derived oxidative stress by an occult infection related S surface antigen variant.

Authors:  In-Kyung Lee; Seoung-Ae Lee; Hong Kim; You-Sub Won; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 3.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

Review 4.  Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment.

Authors:  Giuseppe Castello; Susan Costantini; Stefania Scala
Journal:  J Transl Med       Date:  2010-11-03       Impact factor: 5.531

5.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

6.  Oncogenic potential of hepatitis C virus proteins.

Authors:  Arup Banerjee; Ratna B Ray; Ranjit Ray
Journal:  Viruses       Date:  2010-09-27       Impact factor: 5.818

Review 7.  Mechanical Signaling in the Pathophysiology of Critical Illness Myopathy.

Authors:  Rebeca C Kalamgi; Lars Larsson
Journal:  Front Physiol       Date:  2016-02-04       Impact factor: 4.566

8.  Karonudib is a promising anticancer therapy in hepatocellular carcinoma.

Authors:  Xiangwei Hua; Kumar Sanjiv; Helge Gad; Therese Pham; Camilla Gokturk; Azita Rasti; Zhenjun Zhao; Kang He; Mingxuan Feng; Yunjin Zang; Jianjun Zhang; Qiang Xia; Thomas Helleday; Ulrika Warpman Berglund
Journal:  Ther Adv Med Oncol       Date:  2019-08-23       Impact factor: 8.168

9.  HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice.

Authors:  Michael A Joyce; Kathie-Anne Walters; Sue-Ellen Lamb; Mathew M Yeh; Lin-Fu Zhu; Norman Kneteman; Jason S Doyle; Michael G Katze; D Lorne Tyrrell
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

Review 10.  Hepatitis C virus-induced mitochondrial dysfunctions.

Authors:  Charlène Brault; Pierre L Levy; Birke Bartosch
Journal:  Viruses       Date:  2013-03-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.